Vinci Capital is a private equity general partner firm headquartered in Lausanne, Switzerland.
VC-backed Swiss biotechnology compan Symetis is planning a Zurich IPO, a strong sign for the Swiss healthcare sector.
Iceni Capital has exited Mentor IMC, an oil & gas recruitment firm, to French group Vinci for a 6x return on its investment.
Anergis, a Swiss allergy vaccine developer, has raised CHF8m from Sunstone Capital, BioMed Partners, Vinci Capital and others.
Read more news concerning Vinci Capital
A sampling of Vinci Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?